Lyme and Infectious Disease Information and Fairness in Treatment (LIIFT) Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Authorizes appropriations to the Centers for Disease Control and Prevention to: (1) focus on developing better diagnostic tools and tests, expanding educational efforts, and re-educating clinicians, medical license boards, and health care insurers about the inappropriate uses of the Lyme disease case surveillance definition in patient diagnosis and treatment; and (2) collaborate with the National Institutes of Health, the Department of Defense, and other appropriate agencies for further research on tick-borne disorders, including study of preventive methods to decrease exposure to them.
Requires the Director of the National Institutes of Health to coordinate activities and research regarding tick-borne diseases across Institutes to encourage collaborative research.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF
Cite this page
U.S. Congress. (2026). H.R. 2118: Lyme and Infectious Disease Information and Fairness in Treatment (LIIFT) Act. 107th Congress. Open America. https://openamerica.io/bill/107-HR-2118/
"H.R. 2118: Lyme and Infectious Disease Information and Fairness in Treatment (LIIFT) Act." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-2118/.
H.R. 2118, 107th Cong. (2026), https://openamerica.io/bill/107-HR-2118/.
[H.R. 2118: Lyme and Infectious Disease Information and Fairness in Treatment (LIIFT) Act](https://openamerica.io/bill/107-HR-2118/)